Published by Michele Maatouk on 7th October 2022
(Sharecast News) - Biotech company Oxford BioDynamics said on Friday that it has conditionally raised around £9.1m in a placing to accelerate the commercialisation of a cancer test.
URL: http://www.digitallook.com/dl/news/story/33018805/...